Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Apollo Health Ventures is a transatlantic early-stage venture capital firm founded in 2017, with a strategic presence in both Europe and the United States. The firm is dedicated to co-founding and investing in transformative healthcare companies that specifically target age-related diseases and the aging process itself. With a robust investment strategy, Apollo Health Ventures aims to leverage advancements in biotechnology and health technology to enhance disease prevention and improve the quality of life for individuals facing age-related health challenges.
Since its inception, Apollo Health Ventures has established itself as a key player in the biotech and healthcare sectors, focusing on innovative therapeutics that address the root causes of age-related diseases. The firm employs a unique venture lab approach, collaborating closely with scientific experts and research institutions to create new companies that are at the forefront of healthcare innovation. This collaborative model not only fosters the development of groundbreaking therapies but also ensures that the firms they invest in are well-equipped to navigate the complexities of the healthcare landscape.
With a portfolio comprising 11 companies, Apollo Health Ventures has demonstrated its commitment to supporting early-stage ventures that align with its mission. The firm’s leadership is characterized by a deep understanding of the healthcare market and a passion for driving change through innovation. By focusing on the intersection of biotechnology and healthcare, Apollo Health Ventures is well-positioned to capitalize on emerging trends and contribute to the advancement of medical science.
Apollo Health Ventures specializes in investments within the biotechnology and healthcare sectors, with a particular emphasis on therapeutics that address age-related diseases. The firm’s investment strategy is centered around identifying and supporting innovative companies that are pioneering solutions to some of the most pressing health challenges associated with aging. This includes a focus on therapeutics that not only treat symptoms but also target the underlying causes of age-related conditions.
The firm employs a venture lab approach, which allows it to partner with scientific experts and research institutions to co-found new companies. This model enables Apollo Health Ventures to leverage cutting-edge research and technological advancements, ensuring that the companies it supports are equipped with the necessary resources and expertise to succeed. By fostering collaboration between entrepreneurs and scientists, the firm aims to accelerate the development of transformative healthcare solutions.
Apollo Health Ventures is active in both North America and Europe, allowing it to tap into diverse markets and a wide range of innovative ideas. The firm invests at various stages, including pre-seed, seed, seed-plus, and Series A, providing flexible funding options to meet the needs of early-stage companies. With a keen eye for potential and a commitment to supporting visionary founders, Apollo Health Ventures seeks to back companies that are not only innovative but also have the potential to make a significant impact on global health.
Apollo Health Ventures boasts a diverse portfolio of 11 companies, each contributing to the firm’s mission of advancing healthcare through innovative biotechnology solutions. Notable investments include Aeovian Pharmaceuticals, which focuses on developing therapies for age-related diseases, and Auron Therapeutics, known for its groundbreaking work in the biotech space. Other significant portfolio companies include Bloom Science, Booster Therapeutics, Cleara, Focal Biosciences, Galilei, Haya Therapeutics, Ochre Bio, Refoxy Pharma, and Samsara Therapeutics.
These companies represent a range of innovative approaches to tackling age-related health issues, from novel drug development to advanced therapeutic technologies. Apollo Health Ventures actively supports its portfolio companies by providing not only capital but also strategic guidance and access to a network of scientific and industry experts. This comprehensive support system enhances the likelihood of success for the startups in their portfolio, positioning them to achieve significant milestones in the healthcare sector.
The firm’s focus on age-related diseases underscores its commitment to addressing one of the most critical challenges in modern healthcare. By investing in companies that are pioneering solutions in this area, Apollo Health Ventures is not only contributing to the advancement of medical science but also improving the quality of life for individuals affected by age-related conditions.
To pitch Apollo Health Ventures, founders should visit their website at apollo.vc. They welcome pitches that clearly outline the business model and market opportunity, particularly those that align with their focus on age-related diseases. It is recommended to provide a concise and compelling presentation of your venture.
Apollo Health Ventures invests in various stages, including pre-seed, seed, seed-plus, and Series A. This flexibility allows them to support startups at different points in their development journey.
Founders interested in pitching to Apollo Health Ventures can do so through their website at apollo.vc. It is advisable to provide a clear overview of the business model, market opportunity, and how the venture aligns with their focus on age-related diseases.
The firm primarily focuses on the biotechnology and healthcare sectors, specifically targeting therapeutics that address age-related diseases. This focus allows them to invest in innovative solutions that have the potential to transform healthcare.
While specific check sizes are not disclosed, Apollo Health Ventures invests at early stages, which typically involves smaller amounts compared to later-stage funding. Their approach is to provide the necessary capital to help startups grow and develop their innovations.
Apollo Health Ventures has a transatlantic presence, investing in both North America and Europe. This geographic focus enables them to tap into diverse markets and innovative healthcare solutions.
Apollo Health Ventures offers comprehensive support to its portfolio companies, including strategic guidance and access to a network of scientific experts. This support is designed to enhance the chances of success for the startups they invest in.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.